Patients eligible for proprotein convertase subtilisin/kexin type9 inhibitors (pcsk9i) after acute myocardial infarction. The ESC position applied to patients included in the FAST-MI 2015 registry
31 August 2019 (14:50 - 15:00)
Organised by:
About the speaker

Regional University Hospital Jean Minjoz, Besancon (France)
6 More presentations in this session

Doctor M. Cespon Fernandez (Vigo, ES)

Doctor T. Mahendiran (Aalst, BE)
Access the full session
The Event
ESC Congress 2019
31 August 2019
14:50 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation






